Daughter employed by the Company in a non-executive position; received total compensation and participated in employee benefit plans on the same basis as similarly situated employees.
| Officer | Age | In this role | 2025 pay | Source |
|---|---|---|---|---|
|
Reshma Kewalramani
Also a director
Chief Executive Officer and President
|
53 |
Since 2020
6 years
|
$21,144,261 | |
|
Jeffrey M. Leiden
Also a director
Executive Chairman
|
70 |
Since 2020
6 years
|
Not reported | |
|
Jonathan Biller
Executive Vice President, Chief Legal Officer
|
62 |
Since 2022
4 years
|
Not reported | |
|
Carmen Bozic
EVP and CMO
Title from the Form 4 dated Jun 26, 2026
|
63 | Not stated | $6,646,321 | |
|
Mark Bunnage
Executive Vice President, Chief Scientific Officer
|
57 |
Since 2026
this year
|
Not reported | |
|
Duncan J. McKechnie
Executive Vice President, Chief Commercial Officer
|
57 |
Since 2025
1 year
|
Not reported | |
|
Kristen C. Ambrose
Senior Vice President, Chief Accounting Officer
|
49 |
Since 2021
5 years
|
Not reported | |
|
Joy Liu
EVP and Chief Legal Officer
Title from the Form 4 dated Jul 1, 2026
|
Not stated | Not stated | Not reported | |
|
E. Morrow “Morrey” Atkinson, III
Executive Vice President, Chief Technical Operations Officer, Head of Biopharmaceutical Science and Manufacturing Operations
|
60 | Not stated | Not reported | |
|
Amit K. Sachdev
EVP Chief Patient & Ext Af Off
Title from the Form 4 dated Jul 21, 2026
|
58 | Not stated | $6,777,243 | |
|
Ourania “Nia” Tatsis
EVP, Chief Reg. & Quality Off.
Title from the Form 4 dated Jul 21, 2026
|
56 | Not stated | $6,974,920 | |
|
Charles F. Wagner, Jr.
EVP, CO & FO
Title from the Form 4 dated Nov 12, 2026
|
57 | Not stated | $8,241,809 | |
|
Grunsven Jasper van
EVP, CP and NPPO
Title from the Form 4 dated Sep 8, 2026
|
Not stated | Not stated | Not reported |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
From the proxy statement filed Apr 2, 2026 · updated by the 8-Ks of Apr 29, 2026 and Oct 20, 2026
| Director | Age | On board | Independent | Committees | Other public boards | 2025 pay | Source |
|---|---|---|---|---|---|---|---|
|
Jeffrey Leiden
Board chair
|
70 |
2009
17 years
|
Not stated | None stated | None stated | Not stated | |
|
Reshma Kewalramani
CEO
|
53 |
2020
6 years
|
Not stated | None stated | None stated | Paid as CEO | |
|
Bruce Sachs
Lead independent director
|
66 |
1998
28 years
|
Independent |
Management Development and Compensation Committee · Chair
Corporate Governance and Nominating Committee
|
None stated | $615,130 | |
|
Sangeeta Bhatia
|
57 |
2015
11 years
|
Independent |
Science and Technology Committee · Chair
Corporate Governance and Nominating Committee
|
None stated | $560,364 | |
|
Lloyd Carney
|
64 |
2019
7 years
|
Independent |
Corporate Governance and Nominating Committee · Chair
Audit and Finance Committee
|
Visa Inc., Grid Dynamics Holdings Inc. | $565,364 | |
|
Alan Garber
|
70 |
2017
9 years
|
Independent |
Corporate Governance and Nominating Committee
Science and Technology Committee
|
None stated | $545,247 | |
|
Michel Lagarde
|
52 |
2023
3 years
|
Independent |
Audit and Finance Committee
|
None stated | $540,130 | |
|
Diana McKenzie
|
61 |
2020
6 years
|
Independent |
Audit and Finance Committee
Management Development and Compensation Committee
|
MetLife Inc., agilon health, inc. | $552,864 | |
|
Jennifer Schneider
|
51 |
2024
2 years
|
Independent |
Management Development and Compensation Committee
|
None stated | $537,864 | |
|
Nancy Thornberry
|
69 |
2023
3 years
|
Independent |
Science and Technology Committee
|
Denali Therapeutics, Schrödinger Inc. | $528,247 | |
|
Daniel Brennan
Joined Oct 20, 2026
|
- | - | - |
Audit and Finance Committee
|
- | - |
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.
Daughter employed by the Company in a non-executive position; received total compensation and participated in employee benefit plans on the same basis as similarly situated employees.
Loading...